Top Markets
#1 MowCat MowCat +49.01%
#2 Derive Derive +22.98%
#3 Audiera Audiera +21.36%
#4 Velvet Velvet +19.74%
#5 Biconomy Biconomy +17.74%
#6 Geodnet Geodnet +16.44%
#7 aPriori aPriori +13.80%
#8 Quack AI Quack AI +13.49%
#9 Cross Cross +13.44%
#10 Humanity Humanity +11.22%
Coin of the day
MowCat MowCat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Silo Pharma, Inc. Silo Pharma, Inc.

Silo Pharma, Inc.

SILO
Classifica tra le azioni #35574
Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm... Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems. Leading its pipeline is SPC-15, an intranasal treatment engineered to address post-traumatic stress disorder (PTSD) and anxiety disorders stemming from stress. Another key development is SP-26, a time-release, ketamine-loaded implant designed to provide relief for fibromyalgia and chronic pain. Furthermore, Silo Pharma is advancing two preclinical programs: SPC-14, an intranasal compound targeting Alzheimer's disease, and SPU-16, a CNS-homing peptide intended for the management of multiple sclerosis (MS). The company's research and development efforts frequently involve collaborations with prominent academic institutions such as Columbia University and the University of Maryland, Baltimore. Founded in 2010, the company adopted its current name, Silo Pharma, Inc., in September 2020, having previously operated as Uppercut Brands, Inc. Silo Pharma is headquartered in Sarasota, Florida.
Prezzo delle azioni
$3.29
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$3.71M
Variazione (1 giorno)
2.17%
Variazione (1 anno)
-69.11%
Paese
US
Scambia Silo Pharma, Inc. (SILO)

Categoria

Healthcare
Storico del prezzo dell'azione per Silo Pharma, Inc. (SILO)
Prezzo di chiusura più alto: $3.62 il 2026-08-01

Prezzo di chiusura più basso: $267.20 il 2021-01-01
Storico del prezzo dell'azione di Silo Pharma, Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 8.04%
2025 -55.42%
2024 -38.14%
2023 -54.07%
2022 -57.00%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE